KIRITSY CHRISTOPHER P exercised Palvella Therapeutics Options at $127.20 per share and sold the related shares at $157 on Sep. 2, 2026. The director’s reported derivative holdings fell to zero afterward, while the transaction also changed his direct share ownership.
Key Highlights
- The option exercise was recorded under SEC transaction code M.
- The subsequent Palvella share sale carried SEC transaction code S.
- KIRITSY CHRISTOPHER P’s reported derivative holdings reached zero after the transactions.
KIRITSY CHRISTOPHER P exercised options in Palvella Therapeutics at $127.20 per share on Sep. 2, 2026, then sold the related shares at $157 per share the same day. The director’s reported derivative holdings were zero after the transactions.
Option Exercise and Same-Day Sale
The option exercise was recorded under SEC transaction code M. A separate transaction recorded the sale of Palvella shares at $157 per share under code S. The source identifies KIRITSY CHRISTOPHER P as a director of Palvella Therapeutics. The transactions took place on Sep. 2, 2026.
Reported Ownership After Transactions
Following the option exercise, KIRITSY CHRISTOPHER P’s reported direct share ownership was higher than after the subsequent sale. The share sale reduced that direct ownership. The reported derivative securities balance was zero after the option exercise transaction. The sequence therefore left separate direct and derivative holdings at different reported levels.
FAQs
Q: What did KIRITSY CHRISTOPHER P do in the Palvella insider transaction?
A: KIRITSY CHRISTOPHER P exercised Palvella Therapeutics options at $127.20 per share and later sold the related shares at $157 per share on Sep. 2, 2026.
Q: What was the impact of the Palvella insider sale?
A: The transaction reduced KIRITSY CHRISTOPHER P’s reported direct share ownership after the sale. Reported derivative securities holdings were zero afterward.
Q: What SEC codes applied to the Palvella transactions?
A: The option exercise for 313 shares was reported under SEC transaction code M. The subsequent sale of 313 Palvella shares was reported under SEC transaction code S.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.